Publications and research
Scientific publications
Andresen, Nikolai Kragøe; Røssevold, Andreas Hagen; Borgen, Elin; Schirmer, Cecilie; Gilje, Bjørnar; Garred, Øystein; Lømo, Jon; Stensland, Marius; Nordgård, Oddmund; Falk, Ragnhild Sørum; Ruud, Randi Margit; Russnes, Hege Elisabeth Giercksky;
Kyte, Jon A
; Naume, Bjørn
(2024).
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials.
Molecular Oncology.
https://doi.org/10.1002/1878-0261.13675
Jin, Yixin; Dunn, Claire; Persiconi, Irene; Sike, Adam; Skorstad, Gjertrud; Beck, Carole Anne;
Kyte, Jon A
(2024).
Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers.
International Journal of Molecular Sciences.
Vol. 25.
https://doi.org/10.3390/ijms25010586
Andresen, Nikolai Kragøe; Røssevold, Andreas Hagen; Quaghebeur, Claire; Gilje, Bjørnar; Boge, Beate; Gombos, Andrea; Falk, Ragnhild Sørum; Mathiesen, Randi Margit Ruud; Julsrud, Lars; Garred, Øystein; Russnes, Hege Elisabeth Giercksky; Lereim, Ragnhild Reehorst; Chauhan, Sudhir Kumar; Lingjærde, Ole Christian; Dunn, Claire; Naume, Bjørn;
Kyte, Jon A
(2024).
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: A randomized phase 2b trial.
Journal for ImmunoTherapy of Cancer (JITC).
Vol. 12:e007990.
https://doi.org/10.1136/jitc-2023-007990
Chauhan, Sudhir Kumar; Dunn, Claire; Andresen, Nikolai Kragøe; Røssevold, Andreas Hagen; Skorstad, Gjertrud; Sike, Adam; Gilje, Bjørnar; Raj, Sunil Xavier; Huse, Kanutte; Naume, Bjørn;
Kyte, Jon A
(2024).
Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation.
NPJ breast cancer.
Vol. 10.
https://doi.org/10.1038/s41523-024-00638-2
Gombos, A.; Goncalves, A.; Curigliano, G.; Bartsch, R.;
Kyte, Jon A
; Ignatiadis, M.; Awada, A.
(2023).
How I treat endocrine-dependent metastatic breast cancer.
ESMO Open.
Vol. 8.
https://doi.org/10.1016/j.esmoop.2023.100882
Beck, Carole Anne; Casey, Nicholas Paul; Persiconi, Irene; Nejati Moharrami, Neda; Sike, Adam; Jin, Yixin;
Kyte, Jon A
(2023).
Development of a TGFβ—IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy.
Biomedicines.
Vol. 11.
https://doi.org/10.3390/biomedicines11020459
Røssevold, Andreas Hagen; Andresen, Nikolai Kragøe; Bjerre, Christina Annette; Gilje, Bjørnar; Jakobsen, Erik Hugger; Raj, Sunil Xavier; Falk, Ragnhild Sørum; Russnes, Hege Elisabeth Giercksky; Jahr, Thea; Ruud, Randi Margit; Lømo, Jon; Garred, Øystein; Chauhan, Sudhir Kumar; Lereim, Ragnhild Reehorst; Dunn, Claire; Naume, Bjørn;
Kyte, Jon A
(2022).
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial.
Nature Medicine.
https://doi.org/10.1038/s41591-022-02126-1
Aamdal, Elin; Skovlund, Eva; Jacobsen, Kari Dolven; Straume, Oddbjørn; Kersten, Christian; Herlofsen, Oluf; Karlsen, Jarle; Hussain, Israr; Amundsen, Anita; Dalhaug, Astrid; Nyakas, Marta Sølvi; Hagene, Kirsten Thorin; Holmsen, Kjersti; Aamdal, Steinar; Kaasa, Stein; Guren, Tormod Kyrre;
Kyte, Jon A
(2022).
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment.
ESMO Open.
Vol. 7.
https://doi.org/10.1016/j.esmoop.2022.100588
Dorraji, Seyed Esmaeil; Borgen, Elin; Segura-Pena, Dario; Rawat, Puneet; Smorodina, Eva; Dunn, Claire; Greiff, Victor; Sekulic, Nikolina; Russnes, Hege Elisabeth Giercksky;
Kyte, Jon A
(2022).
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform.
Cancers.
Vol. 14:4859.
https://doi.org/10.3390/cancers14194859
Jin, Yixin; Lorvik, Kristina Berg; Jin, Yang; Beck, Carole; Sike, Adam; Persiconi, Irene; Kvaløy, Emilie; Saatcioglu, Fahri; Dunn, Claire;
Kyte, Jon A
(2022).
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.
17 p.
Molecular Therapy Oncolytics.
Vol. 26.
https://doi.org/10.1016/j.omto.2022.06.007